BR112021009341A2 - peptídeos e composições farmacêuticas para o tratamento de doenças oculares - Google Patents
peptídeos e composições farmacêuticas para o tratamento de doenças oculares Download PDFInfo
- Publication number
- BR112021009341A2 BR112021009341A2 BR112021009341-9A BR112021009341A BR112021009341A2 BR 112021009341 A2 BR112021009341 A2 BR 112021009341A2 BR 112021009341 A BR112021009341 A BR 112021009341A BR 112021009341 A2 BR112021009341 A2 BR 112021009341A2
- Authority
- BR
- Brazil
- Prior art keywords
- fact
- compound
- formula
- alkyl
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Immunology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862767180P | 2018-11-14 | 2018-11-14 | |
| US62/767,180 | 2018-11-14 | ||
| PCT/IB2019/001220 WO2020099925A2 (en) | 2018-11-14 | 2019-11-14 | Peptides and pharmaceutical compositions for treating eye diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021009341A2 true BR112021009341A2 (pt) | 2021-08-10 |
Family
ID=70732068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021009341-9A BR112021009341A2 (pt) | 2018-11-14 | 2019-11-14 | peptídeos e composições farmacêuticas para o tratamento de doenças oculares |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3880690A4 (https=) |
| JP (1) | JP7522732B2 (https=) |
| KR (1) | KR20210087539A (https=) |
| CN (1) | CN113474356B (https=) |
| AU (1) | AU2019378162B2 (https=) |
| BR (1) | BR112021009341A2 (https=) |
| MX (1) | MX2021005077A (https=) |
| SG (1) | SG11202104178TA (https=) |
| TW (1) | TWI865470B (https=) |
| WO (1) | WO2020099925A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2766160C2 (ru) | 2017-05-17 | 2022-02-08 | Юю Фарма, Инк. | Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| BR112021023477A2 (pt) | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
| CA3170606A1 (en) * | 2020-03-05 | 2021-09-30 | Wonsang YU | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
| EP4450079A4 (en) * | 2021-12-13 | 2025-12-10 | Eyebiokorea Inc | COMPOSITION FOR THE TREATMENT OF MACULAR DEGENERATION COMPRISING A NEW PEPTIDE |
| KR102662922B1 (ko) * | 2022-05-31 | 2024-05-03 | 주식회사 세네릭스 | 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| KR101690539B1 (ko) * | 2015-07-30 | 2016-12-29 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| EP3539559B1 (en) * | 2016-04-08 | 2020-08-26 | Eyebio Korea | Collagen type ii alpha-1-based peptide for use in the treatment of macular degeneration |
| KR101795653B1 (ko) * | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR20180074928A (ko) * | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 동물 의약품 조성물 |
| RU2766160C2 (ru) * | 2017-05-17 | 2022-02-08 | Юю Фарма, Инк. | Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента |
-
2019
- 2019-11-13 TW TW108141290A patent/TWI865470B/zh active
- 2019-11-14 JP JP2021526304A patent/JP7522732B2/ja active Active
- 2019-11-14 SG SG11202104178TA patent/SG11202104178TA/en unknown
- 2019-11-14 CN CN201980078779.XA patent/CN113474356B/zh active Active
- 2019-11-14 WO PCT/IB2019/001220 patent/WO2020099925A2/en not_active Ceased
- 2019-11-14 EP EP19883897.1A patent/EP3880690A4/en active Pending
- 2019-11-14 AU AU2019378162A patent/AU2019378162B2/en active Active
- 2019-11-14 MX MX2021005077A patent/MX2021005077A/es unknown
- 2019-11-14 BR BR112021009341-9A patent/BR112021009341A2/pt unknown
- 2019-11-14 KR KR1020217018226A patent/KR20210087539A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020099925A3 (en) | 2020-06-25 |
| WO2020099925A2 (en) | 2020-05-22 |
| JP7522732B2 (ja) | 2024-07-25 |
| CN113474356B (zh) | 2024-12-17 |
| SG11202104178TA (en) | 2021-05-28 |
| AU2019378162B2 (en) | 2025-01-30 |
| JP2022507404A (ja) | 2022-01-18 |
| EP3880690A4 (en) | 2023-09-13 |
| EP3880690A2 (en) | 2021-09-22 |
| CA3119921A1 (en) | 2020-05-22 |
| CN113474356A (zh) | 2021-10-01 |
| MX2021005077A (es) | 2021-08-11 |
| KR20210087539A (ko) | 2021-07-12 |
| AU2019378162A1 (en) | 2021-05-20 |
| TW202031675A (zh) | 2020-09-01 |
| TWI865470B (zh) | 2024-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021009341A2 (pt) | peptídeos e composições farmacêuticas para o tratamento de doenças oculares | |
| KR102498428B1 (ko) | 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물 | |
| BR112020014202A2 (pt) | compostos de 1,2,4-oxadiazol como inibidores de vias de sinalização cd47 | |
| CN107427477A (zh) | 作为免疫调节剂的1,2,4‑噁二唑和噻二唑化合物 | |
| JP2002517444A (ja) | メラノコルチン受容体作動薬としてのスピロピペリジン誘導体 | |
| TW200838536A (en) | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor | |
| US20230146455A1 (en) | Treatment of inflammatory diseases with peptides and pharmaceutical compositions | |
| TW202233176A (zh) | 黑皮質素受體促效劑化合物之晶型ｉｉ及其製備方法 | |
| US20230312648A1 (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| JP2004527496A (ja) | 新規物質 | |
| RU2819399C2 (ru) | Пептиды и фармацевтические композиции для лечения глазных болезней | |
| CA3119921C (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| JP2020529435A (ja) | 脂質化ペプチドの水溶性塩、その製造方法および用途 | |
| HK40061089B (zh) | 用於治疗眼病的肽和药物组合物 | |
| HK40061089A (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| CN102215842A (zh) | 含有吡啶-3-甲醛o-(哌啶-1-基-丙基)-肟衍生物作为有效成分的脉络膜视网膜变性疾病的治疗剂 | |
| HK40017864A (en) | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient | |
| BR112017019303B1 (pt) | Compostos de 1,2,4-oxadiazol e tiadiazol como imunomoduladores |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |